Where ideas
meet capital
Where ideas meet capital
HEMEX contributes as a smart money investor with strong clinical development expertise to the healthcare of tomorrow. With skin in the game, we act as a long-term partner that can assist in data collection.
Our investments are entirely focused on regulated healthcare products and technologies, which meet the United Nations’ sustainable development goals (SDGs 3,4 and 3,7 and 3d). Along with our follow-up investments in high performing portfolio companies, we aim to pursue 2-3 new projects per year, preferably from series A onwards.
Investment focus
Teams with a high degree of dedication, competence, and focus.
A game-changing solution for regulated healthcare.
United Nations’ sustainable development goals (SDGs 3,4 and 3,7 and 3d) are aligned with the innovation.
Geographical investment focus is Switzerland & Europe.
Clarity on Patent and IP.
Business models that generate sustainable value.
With the involvement of experts in relevant fields, we have an unbiased multi-step approach. Our investment committee makes the final decision based on a thorough and objective fact-base. Investment decisions are made unanimously by the investment committee.
“HEMEX empowers innovation in healthcare and actively supports portfolio companies to reach their next milestones to create shareholder value.”
Fundraising workshop
Gain practical experience in raising money from investors. Our Fundraising workshop can be paid via Innosuisse’s coaching program.
Investment news
What customers say about us
With its impressive commitment to advance and fund healthcare innovations, its deep understanding of startup needs and its solid expertise in supporting regulatory and clinical operations, HEMEX is an exceptional partner that has been and continues to be instrumental in our journey.
Mathieu Horras
CEO, ASPIVIX
We have worked with HEMEX on several topics, including fundraising and communication. They have supported us with their expertise and network. We value this partnership, and we look forward to our continued collaborations.
Eugenie Nicoud
COO, Sedimentum